MOREFIELD GROUP NV (MORE.AS) Fundamental Analysis & Valuation

AMS:MORE • CWN814651014

Current stock price

0.83 EUR
0 (0%)
Last:

This MORE.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MORE.AS Profitability Analysis

1.1 Basic Checks

  • MORE had positive earnings in the past year.
  • In the past year MORE had a positive cash flow from operations.
  • In the past 5 years MORE has always been profitable.
  • The reported operating cash flow has been mixed in the past 5 years: MORE reported negative operating cash flow in multiple years.
MORE.AS Yearly Net Income VS EBIT VS OCF VS FCFMORE.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

  • MORE has a Return On Assets (1.83%) which is in line with its industry peers.
  • MORE has a Return On Equity of 10.10%. This is in the better half of the industry: MORE outperforms 61.29% of its industry peers.
  • MORE's Return On Invested Capital of 8.40% is fine compared to the rest of the industry. MORE outperforms 70.97% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MORE is in line with the industry average of 10.85%.
  • The 3 year average ROIC (12.56%) for MORE is well above the current ROIC(8.40%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.83%
ROE 10.1%
ROIC 8.4%
ROA(3y)5.52%
ROA(5y)5.61%
ROE(3y)21.44%
ROE(5y)15.2%
ROIC(3y)12.56%
ROIC(5y)N/A
MORE.AS Yearly ROA, ROE, ROICMORE.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.75%, MORE is in line with its industry, outperforming 51.61% of the companies in the same industry.
  • The Operating Margin of MORE (6.05%) is better than 67.74% of its industry peers.
  • MORE has a Gross Margin of 65.48%. This is comparable to the rest of the industry: MORE outperforms 54.84% of its industry peers.
Industry RankSector Rank
OM 6.05%
PM (TTM) 1.75%
GM 65.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MORE.AS Yearly Profit, Operating, Gross MarginsMORE.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. MORE.AS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MORE is creating value.
  • The number of shares outstanding for MORE remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for MORE has been increased compared to 5 years ago.
  • Compared to 1 year ago, MORE has an improved debt to assets ratio.
MORE.AS Yearly Shares OutstandingMORE.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MORE.AS Yearly Total Debt VS Total AssetsMORE.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of 0.82, we must say that MORE is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.82, MORE is doing worse than 80.65% of the companies in the same industry.
  • MORE has a Debt/Equity ratio of 1.45. This is a high value indicating a heavy dependency on external financing.
  • MORE's Debt to Equity ratio of 1.45 is on the low side compared to the rest of the industry. MORE is outperformed by 64.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.45
Debt/FCF N/A
Altman-Z 0.82
ROIC/WACC1.44
WACC5.82%
MORE.AS Yearly LT Debt VS Equity VS FCFMORE.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • MORE has a Current Ratio of 0.73. This is a bad value and indicates that MORE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of MORE (0.73) is worse than 61.29% of its industry peers.
  • A Quick Ratio of 0.57 indicates that MORE may have some problems paying its short term obligations.
  • MORE has a worse Quick ratio (0.57) than 74.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.57
MORE.AS Yearly Current Assets VS Current LiabilitesMORE.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

3. MORE.AS Growth Analysis

3.1 Past

  • MORE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -62.44%.
  • MORE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.94% yearly.
  • MORE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.29%.
EPS 1Y (TTM)-62.44%
EPS 3Y2.94%
EPS 5YN/A
EPS Q2Q%6.67%
Revenue 1Y (TTM)19.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%25.87%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MORE.AS Yearly Revenue VS EstimatesMORE.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2022 2023 2024 50M 100M

1

4. MORE.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • MORE is valuated quite expensively with a Price/Earnings ratio of 27.67.
  • The rest of the industry has a similar Price/Earnings ratio as MORE.
  • MORE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.67
Fwd PE N/A
MORE.AS Price Earnings VS Forward Price EarningsMORE.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MORE indicates a rather cheap valuation: MORE is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.42
MORE.AS Per share dataMORE.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. MORE.AS Dividend Analysis

5.1 Amount

  • No dividends for MORE!.
Industry RankSector Rank
Dividend Yield 0%

MORE.AS Fundamentals: All Metrics, Ratios and Statistics

MOREFIELD GROUP NV

AMS:MORE (3/17/2026, 7:00:00 PM)

0.83

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.22%
Ins Owner ChangeN/A
Market Cap9.01M
Revenue(TTM)120.53M
Net Income(TTM)2.11M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 27.67
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF 0.45
P/B 0.43
P/tB 2.9
EV/EBITDA 1.42
EPS(TTM)0.03
EY3.61%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)1.84
OCFY221.9%
SpS11.11
BVpS1.93
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.14
Profitability
Industry RankSector Rank
ROA 1.83%
ROE 10.1%
ROCE 12.73%
ROIC 8.4%
ROICexc 10.57%
ROICexgc 17.33%
OM 6.05%
PM (TTM) 1.75%
GM 65.48%
FCFM N/A
ROA(3y)5.52%
ROA(5y)5.61%
ROE(3y)21.44%
ROE(5y)15.2%
ROIC(3y)12.56%
ROIC(5y)N/A
ROICexc(3y)14.8%
ROICexc(5y)N/A
ROICexgc(3y)16.97%
ROICexgc(5y)N/A
ROCE(3y)19.03%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 1.45
Debt/FCF N/A
Debt/EBITDA 1.5
Cap/Depr 166.35%
Cap/Sales 17.78%
Interest Coverage 250
Cash Conversion 99.03%
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.57
Altman-Z 0.82
F-Score4
WACC5.82%
ROIC/WACC1.44
Cap/Depr(3y)162.93%
Cap/Depr(5y)N/A
Cap/Sales(3y)12.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-62.44%
EPS 3Y2.94%
EPS 5YN/A
EPS Q2Q%6.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%25.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-174.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y116.2%
OCF growth 3YN/A
OCF growth 5YN/A

MOREFIELD GROUP NV / MORE.AS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MOREFIELD GROUP NV (MORE.AS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MORE.AS.


What is the valuation status of MOREFIELD GROUP NV (MORE.AS) stock?

ChartMill assigns a valuation rating of 1 / 10 to MOREFIELD GROUP NV (MORE.AS). This can be considered as Overvalued.


What is the profitability of MORE stock?

MOREFIELD GROUP NV (MORE.AS) has a profitability rating of 5 / 10.


What is the financial health of MOREFIELD GROUP NV (MORE.AS) stock?

The financial health rating of MOREFIELD GROUP NV (MORE.AS) is 1 / 10.